Objectives: The objective of the implementation of the IFRHA® methodology is to replace this synthesis deficit locally with very high doses of HA, with a hydrobooster that does not generate volume or changes in facial structure.
Introduction: The synthesis capacity of hyaluronic acid (HA) decreases throughout the life of a human being, which leads to morphological and functional changes in our skin. This decrease in its synthesis is much more evident in specific periods of life. One of these periods where this process is accelerated is the peri- and postmenopausal period of women, where the decrease in estrogen receptors and levels (much more evident in facial skin), causes very rapid changes in the quality of the skin: decreased skin thickness, atrophy, loss of elasticity, dehydration and increased the wrinkles.
Materials / method: A descriptive observational cohort study was carried out on 15 female patients over 50 years of age, where the safety and efficacy of intradermal injection with high dose at the facial level of a hydrobooster with minimally cross-linked HA (Dorothy®) has been evaluated. Using a fan and linear threading technique, 2 sessions were carried out separated by 1 month and the results were assessed 3 months after the first session. A photographic study was carried out, a sample of the basic skin parameters was taken with a probe and the pain scale and the degree of patient satisfaction were recorded.
Results: The results obtained with intradermotherapy with high doses of a hydrobooster such as Dorothy®, have been able to demonstrate the high effectiveness of this procedure, with significant improvement in all the basic parameters of the skin, being a safe procedure, very minimally invasive and with minimal side effects. All patients reported a high degree of satisfaction.
Disclosures
Did you receive any funding to support your research for this TOPIC?
No
Were you provided with any honoraria, payment or other compensation for your work on this study?
No
Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No
Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No
This work was not supported by any direct or non direct funding. It is under the author's own responsability